2.20 TWD
143.94 M TWD
4.59 B TWD
40.91 M
About ORIENT EUROPHARMA CO
Sector
CEO
Mon Lin Tsai
Headquarters
Taipei
Website
Founded
1982
ISIN
TW0004120001
FIGI
BBG000BNXGT3
Orient Europharma Co. Ltd. engages in the manufacturing and trading of western medicine, health food and cosmetics. The company was founded in 1982 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4120 is 48.10 TWD — it has increased by 0.21% in the past 24 hours. Watch ORIENT EUROPHARMA CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ORIENT EUROPHARMA CO stocks are traded under the ticker 4120.
4120 stock has risen by 2.01% compared to the previous week, the month change is a −2.13% fall, over the last year ORIENT EUROPHARMA CO has showed a 23.33% increase.
4120 reached its all-time high on Sep 9, 2013 with the price of 111.00 TWD, and its all-time low was 9.75 TWD and was reached on Jun 30, 2005. View more price dynamics on 4120 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4120 stock is 0.73% volatile and has beta coefficient of 0.33. Track ORIENT EUROPHARMA CO stock price on the chart and check out the list of the most volatile stocks — is ORIENT EUROPHARMA CO there?
Today ORIENT EUROPHARMA CO has the market capitalization of 4.18 B, it has increased by 2.12% over the last week.
Yes, you can track ORIENT EUROPHARMA CO financials in yearly and quarterly reports right on TradingView.
4120 net income for the last quarter is 11.38 M TWD, while the quarter before that showed −70.55 M TWD of net income which accounts for 116.12% change. Track more ORIENT EUROPHARMA CO financial stats to get the full picture.
Yes, 4120 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 2.08%. Tracking ORIENT EUROPHARMA CO dividends might help you take more informed decisions.
As of Dec 30, 2024, the company has 834.00 employees. See our rating of the largest employees — is ORIENT EUROPHARMA CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORIENT EUROPHARMA CO EBITDA is 313.91 M TWD, and current EBITDA margin is 6.25%. See more stats in ORIENT EUROPHARMA CO financial statements.
Like other stocks, 4120 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORIENT EUROPHARMA CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORIENT EUROPHARMA CO technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORIENT EUROPHARMA CO stock shows the buy signal. See more of ORIENT EUROPHARMA CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.